文献速递神经PETCT

临床18F-FDG与淀粉样蛋白脑正电子发射断层/CT在认知障碍检查中的应用:现况如何

Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?
PubMed 文献 · Br J Radiol · 2019-05-14

本文综述18F-FDG PET/CT与淀粉样蛋白PET/CT在认知障碍检查中的作用,概述两者适应证、作用机制、技术、患者准备与采集参数,并提供常见认知障碍的判读框架及避免判读陷阱的提示。

要点

  • 18F-FDG PET/CT反映脑葡萄糖代谢,用于认知障碍的检查。
  • 淀粉样蛋白PET/CT可能从根本上改变阿尔茨海默病的管理。
  • 综述提供常见认知障碍的判读框架及避免判读陷阱的提示。

核心结论

  • 18F-FDG PET/CT有助于认知障碍的检查,淀粉样蛋白PET/CT的出现可能从根本上改变最常见痴呆类型阿尔茨海默病的管理。

研究设计与样本

  • 综述,旨在帮助读者理解18F-FDG PET/CT在认知障碍检查中的作用及淀粉样蛋白PET/CT的影响。

临床应用与阅片要点

  • 综述概述了18F-FDG PET/CT与淀粉样蛋白PET/CT在认知障碍中的适应证。
  • 综述详述了两者的作用机制、技术、患者准备与采集参数。
  • 综述提供了常见认知障碍的判读框架及避免判读陷阱的提示。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The number of people living with dementia is increasing, but as yet there remains no cure or disease-modifying treatment. This review aims to help readers understand the role of 18F-FDG PET/CT imaging in the investigation of cognitive impairment and how the advent of amyloid PET/CT imaging may hold the key to radically changing management of the most common form of dementia - Alzheimer's disease. The indications for 18F-FDG PET/CT and amyloid PET/CT imaging in cognitive impairment are outlined. Additionally, the mechanisms of action, technique, patient preparation and acquisition parameters for both are detailed. We conclude by providing a framework for interpreting 18F-FDG PET/CT and amyloid PET/CT imaging in the more common conditions that lead to cognitive impairment conditions with tips on avoiding pitfalls in interpretation.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Dumba M, Khan S, Patel N, et al. Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now? Br J Radiol. 2019. PMID: 30982329. doi:10.1259/bjr.20181027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。